研究者業績
基本情報
- 所属
- 藤田医科大学 医学部 医学科 ばんたね病院 臨床検査科 教授
- 学位
- 博士(医学)(藤田保健衛生大学)
- J-GLOBAL ID
- 200901097717801760
- researchmap会員ID
- 1000360724
研究分野
1論文
142-
Vaccines 12(7) 786-786 2024年7月17日Preexisting cardiovascular disease (CVD) is a pivotal risk factor for severe coronavirus disease 2019 (COVID-19). We investigated the longitudinal (over 1 year and 9 months) humoral and cellular responses to primary series and booster doses of mRNA COVID-19 vaccines in patients with CVD. Twenty-six patients with CVD who received monovalent mRNA COVID-19 vaccines were enrolled in this study. Peripheral blood samples were serially drawn nine times from each patient. IgG against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike receptor-binding domain (RBD) was measured using an enzyme-linked immunosorbent assay. The numbers of interferon-γ-releasing cells in response to SARS-CoV-2 peptides were measured using an enzyme-linked immunospot assay. The RBD-IgG titers increased 2 weeks after the primary series and booster vaccination and waned 6 months after vaccination. The S1-specific T cell responses in patients aged < 75 years were favorable before and after booster doses; however, the Omicron BA.1-specific T cell responses were poor. These results suggest that regular vaccination is useful to maintain long-term antibody levels and has implications for booster dose strategies in patients with CVD. Additional booster doses, including Omicron variant-adapted mRNA vaccines, may be recommended for patients with CVD, regardless of age.
-
Heliyon 10(13) e32452 2024年7月15日The CHA2DS2 -VASc score is a vital clinical tool for evaluating thromboembolic risk in patients with atrial fibrillation (AF). This study investigated the efficacy of the CHA2DS2 -VASc score in a cohort of 737 heterogeneous patients (mean age: 63 years) receiving care in cardiac intensive care units (CICUs), with a creatinine-based estimated glomerular filtration rate (eGFR) of ≥60 mL/min/1.73 m2 upon admission and discharge. Incident chronic kidney disease (CKD) was defined as the emergence of a new-onset eGFR<60 mL/min/1.73 m2, accompanied by a decline of >5 mL/min/1.73 m2 compared to that at discharge. The primary endpoint was the incidence of CKD, and the secondary endpoints included all-cause mortality, cardiovascular events, and progression to end-stage kidney disease. In this cohort, 210 (28 %) patients developed CKD. Multivariate analyses revealed that CHA2DS2 -VASc score was a significant independent predictor of incident CKD, regardless of the presence of AF. Integration of CHA2DS2 -VASc scores with eGFR enhanced the predictive accuracy of incident CKD, as evidenced by the improved C-index, net reclassification improvement, and integrated discrimination improvement values (all p < 0.05). Over the 12-month follow-up period, a composite endpoint was observed in 61 patients (8.3 %), with elevated CHA2DS2 -VASc scores being independently associated with this endpoint. In conclusion, CHA2DS2-VASc scores have emerged as robust predictors of both CKD incidence and adverse outcomes. Their inclusion substantially refined the 12-month risk stratification of patients with preserved renal function hospitalized in the CICUs.
-
日本循環器学会学術集会抄録集 88回 PJ043-1 2024年3月
-
Scientific reports 14(1) 75-75 2024年1月2日The renal angina index (RAI) is a validated scoring tool for predicting acute kidney injury (AKI). We investigated the efficacy of the RAI in 2436 heterogeneous patients (mean age, 70 years) treated in cardiac intensive care units (CICUs). The RAI was calculated from creatinine and patient condition scores. AKI was diagnosed by the Kidney Disease: Improving Global Outcome criteria. The primary and secondary endpoints were the development of severe AKI and all-cause mortality, respectively. Four hundred thirty-three patients developed AKI, 87 of them severe. In multivariate analyses, the RAI was a significant independent predictor of severe AKI. During the 12-month follow-up period, 210 patients suffered all-cause death. Elevated RAI was independently associated with all-cause mortality, as was NT-proBNP (p < 0.001). The RAI is a potent predictor not only of severe AKI but also of adverse outcomes and substantially improved the 12-month risk stratification of patients hospitalized in CICUs.
MISC
248-
Circulation journal : official journal of the Japanese Circulation Society 73 742-742 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 381-381 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 380-381 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 608-608 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 614-614 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 648-648 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 312-312 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 311-311 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 302-302 2009年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 73 311-312 2009年3月1日
-
日本臨床検査自動化学会会誌 34(3) 329-333 2009年 査読有り
-
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 16(4) 410-418 2009年 査読有りAim: A new antibody reacted with an epitope in Lp(a) that has undergone oxidation treatment, but is not present in native Lp(a), was developed. Thus, we determined serum oxidized Lp(a) concentration in healthy volunteers, and coronary artery disease (CAD), diabetes mellitus (DM), and hypertensive patients. Methods: We measured serum levels of oxidized Lp(a), Lp(a), LDL-cholesterol and HDL-cholesterol in 122 consecutive patients who underwent routine coronary angiography and had significant coronary artery stenosis (> 75%), and 164 age-matched healthy volunteers. Moreover, serum native Lp(a), oxidized Lp(a) concentration, and pulse wave velocity (PWV) were determined in 181 hypertensive patients. Results: Oxidized Lp(a) level in CAD patients with DM was significantly higher than in healthy volunteers (p < 0.01). Moreover, serum oxidized Lp(a) concentration showed a significant positive correlation with pulse wave velocity, an index of arteriosclerosis (r = 0.431, p < 0.01). Of importance, the deposition of oxidized Lp(a) was readily detected in calcified areas of coronary arteries in patients with myocardial infarction. Conclusion: The present study demonstrated that oxidized Lp(a) may be a new risk factor for coronary artery disease. As the deposition of oxidized Lp(a) was detected in calcified areas of coronary arteries, oxidized Lp(a) might be implicated in endothelial dysfunction.
-
NEPHRON CLINICAL PRACTICE 113(3) C222-C233 2009年 査読有りBackground/Aims: To clarify the clinical significance of tumor necrosis factor (TNF) receptors in patients with myeloperoxidase (MPO)-anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis, we evaluated the cell surface expression of TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2). Patients and Methods: 43 patients with MPO-ANCA-associated vasculitis, 16 patients with chronic renal failure, 10 patients with sepsis, 15 patients with systemic lupus erythematosus, and 18 healthy controls were enrolled in this study, and the surface expression levels of TNFR1, TNFR2, CD63, and CD64 on granulocytes were assessed. In 21 patients with MPO-ANCA-associated vasculitis, soluble TNFR1 (sTNFR1), soluble TNFR2 (sTNFR2), and TNF-alpha in the serum were also measured. Results: The surface expression levels of TNFR1 and TNFR2 on granulocytes were significantly higher in patients with MPO-ANCA-associated vasculitis than in the healthy controls, and positively correlated with the Birmingham Vasculitis Activity Score (BVAS). The levels of sTNFR1, sTNFR2, and TNF-alpha in the serum were also significantly higher in patients with MPO-ANCA-associated vasculitis than in the healthy controls. Serum levels of sTNFR1 and sTNFR2 correlated with serum creatinine, while the surface expression of TNFR1 and TNFR2 on the granulocytes did not. There was no significant correlation between the BVAS and CD63 or BVAS and CD64. Conclusion: The surface expression levels of TNFR1 and TNFR2 on granulocytes were upregulated in patients with MPO-ANCA-associated vasculitis and reflected disease activity. Copyright (C) 2009 S. Karger AG, Basel
-
Circulation journal : official journal of the Japanese Circulation Society 72 1084-1084 2008年10月20日
-
Circulation journal : official journal of the Japanese Circulation Society 72 184-185 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 177-177 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 629-629 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 719-720 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 737-737 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 743-743 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 543-543 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 543-543 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 522-522 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 382-383 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 72 252-253 2008年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71(11) 1669-77 2007年11月BACKGROUND: Restenosis still occurs, even with the sirolimus-eluting stent (SES), and the precise mechanisms and the impact of stent fracture on restensosis have not yet been elucidated. METHODS AND RESULTS: Intravascular ultrasound (IVUS)-guided SES implantation was performed in 184 lesions in 151 patients with stable and unstable angina. Serial (pre-, post- and follow-up) quantitative coronary angiography analysis was obtained in 169 lesions in 138 patients (angiographic follow-up rate: 91%) and 12-month clinical follow-up was done in all patients. Restenosis occurred in 13 (7.7%) of 169 lesions. Stent fracture occurred in 4 (2.4%) of 169 lesions at follow-up. Of the 13 restenotic lesions, 8 had intimal hyperplasia, 4 had stent fracture, and 1 had late stent thrombosis at 7 months. Although multivariate logistic regression analysis revealed that minimal lumen area (min-LA) post (p=0.027), total stent length (p=0.003) and diabetes (p=0.032) were significant independent predictors of restenosis, univariate analysis showed that stent fracture was more common in the restenosis than in the non-restenosis groups (p=0.001). CONCLUSIONS: Although min-LA post by IVUS, total stent length by QCA and diabetes are independent predictors for angiographic restenosis, stent fracture occurred in 4 lesions (2.4%) and all of them resulted in restenosis (31% of the restenosis). The impact of stent fracture and its potential role in the development of restenosis deserves further study.
-
Circulation journal : official journal of the Japanese Circulation Society 71 1016-1016 2007年10月20日
-
Circulation journal : official journal of the Japanese Circulation Society 71 1016-1016 2007年10月20日
-
Journal of the American College of Cardiology 50(4) 319-326 2007年7月24日Objectives: To evaluate the feasibility of noninvasive assessment of the characteristics of disrupted atherosclerotic plaques, the authors interrogated the culprit lesions in acute coronary syndromes (ACS) by multislice computed tomography (CT). Background: Disrupted atherosclerotic plaques responsible for ACS histopathologically demonstrate large lipid cores and positive vascular remodeling. It is expected that plaques vulnerable to rupture should bear similar imaging signatures by CT. Methods: Either 0.5-mm × 16-slice or 64-slice CT was performed in 38 patients with ACS and compared with 33 patients with stable angina pectoris (SAP) before percutaneous coronary intervention. The coronary plaques in ACS and SAP were evaluated for the CT plaque characteristics, including vessel remodeling, consistency of noncalcified plaque (NCP <30 HU or 30 HU <NCP <150 HU), and spotty or large calcification. Results: In the CT profile of culprit ACS and SAP lesions, the frequency of 30 HU <NCP <150 HU (100% vs. 100%, p = NS) was not different, and large calcification (22% vs. 55%, p = 0.004) was significantly more frequent in the stable lesions. Positive remodeling (87% vs. 12%, p < 0.0001), NCP <30 HU (79% vs. 9%, p < 0.0001), and spotty calcification (63% vs. 21%, p = 0.0005) were significantly more frequent in the ACS lesions. Presence of all 3 (i.e., positive remodeling, NCP <30 HU, and spotty calcification) showed a high positive predictive value, and absence of all 3 showed a high negative predictive value for the culprit plaques associated with ACS. Conclusions: The CT characteristics of plaques associated with ACS include positive vascular remodeling, low plaque density, and spotty calcification. It is logical to presume that plaques vulnerable to rupture harbor similar characteristics. © 2007 American College of Cardiology Foundation.
-
CLINICAL CHEMISTRY 53(6) A10-A10 2007年6月
-
CLINICAL CHEMISTRY 53(6) A14-A14 2007年6月
-
Long-term prognostic value of cardiac troponin T in end-stage renal disease: 8-year outcome analysisCLINICAL CHEMISTRY 53(6) A14-A14 2007年6月
-
Circulation journal : official journal of the Japanese Circulation Society 71 616-616 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 470-470 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 346-346 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 570-571 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 311-311 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 409-409 2007年3月1日
-
Circulation journal : official journal of the Japanese Circulation Society 71 409-409 2007年3月1日
講演・口頭発表等
192-
78th The Japanese Circulation Sosiety 2014年
-
78th The Japanese Circulation Sosiety 2014年
-
78th The Japanese Circulation Sosiety 2014年
-
78th The Japanese Circulation Sosiety 2014年
-
78th The Japanese Circulation Sosiety 2014年
所属学協会
9共同研究・競争的資金等の研究課題
4-
日本学術振興会 科学研究費助成事業 2022年4月 - 2025年3月
-
日本学術振興会 科学研究費助成事業 2021年4月 - 2024年3月
-
日本学術振興会 科学研究費助成事業 2017年4月 - 2020年3月
-
日本学術振興会 科学研究費助成事業 2012年4月 - 2017年3月